 |
|
(ree-KOM-bih-nunt HYOO-mun in-ter-LOO-kin...)
| | A drug used to increase the number of blood cells, especially platelets, in some cancer patients receiving chemotherapy. Recombinant human interleukin-11 is a form of interleukin-11 (a cytokine normally made by support cells in the bone marrow) that is made in the laboratory. It is a type of biological response modifier. Also called Neumega, oprelvekin, and rhIL-11. |
| Previous Definitions: | receptor, recombinant, recombinant adenovirus-p53, recombinant fowlpox-CEA-MUC-1-TRICOM vaccine, recombinant fowlpox-TRICOM vaccine | | Next Definitions: | recombinant human methionyl stem cell factor, recombinant tissue plasminogen activator, recombinant vaccinia-CEA-MUC-1-TRICOM vaccine, recombinant vaccinia-TRICOM vaccine, reconstructive surgeon |
|
|
